Ignite Creation Date:
2025-12-25 @ 12:43 AM
Ignite Modification Date:
2026-01-24 @ 4:40 AM
Study NCT ID:
NCT00303667
Status:
COMPLETED
Last Update Posted:
2017-12-28
First Post:
2006-03-15
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Donor Natural Killer Cells and Aldesleukin in Treating Patients w/High Risk AML Undergoing Donor Stem Cell Transplant
Sponsor:
Masonic Cancer Center, University of Minnesota
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Acute Myelogenous Leukemia | View |